Zydus Pharmaceuticals Recalls Succinylcholine Chloride Injection Due to Hazards
Zydus Pharmaceuticals recalled 270,125 vials of Succinylcholine Chloride Injection on August 27, 2025. The recall follows failed impurity tests indicating unknown degradation issues. Consumers and healthcare providers must stop using the product immediately and seek guidance.
Product Details
The recalled product is Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL). It is available in 10 mL multiple-dose vials. The affected lot numbers include L400077, L400113, L400372, L400373, and L400374.
The Hazard
The recall stems from out-of-specification test results for unknown degradation impurities. These impurities pose a significant risk to patients receiving the injection.
Reported Incidents
No specific incidents have been reported related to injuries from this product. The hazard classification is deemed high due to potential health risks.
What to Do
Stop using the product immediately. Contact Zydus Pharmaceuticals at the provided channels for guidance on disposal and refunds.
Contact Information
For further information, reach Zydus Pharmaceuticals at 1-800-XXX-XXXX or visit their website. Additional resources are available on the FDA recall page.